the european medicines agency and patient involvement in the drug approval process
Published 4 years ago • 532 plays • Length 57:19Download video MP4
Download video MP3
Similar videos
-
2:28
what is the chmp?
-
3:24:14
ema 25th anniversary symposium new approaches in patient focused cancer drug
-
14:54
‘communication of anticancer drug benefits and related uncertainties to patients and clinicians’
-
1:46
what is the european medicines agency (ema)? what is its role?
-
18:38
the ema perspective on drug approval process in the era of precision medicine
-
43:15
how not to get cancer | endevr documentary
-
13:51
cancer treatments for dogs could also lead to breakthroughs for humans | 60 minutes
-
5:21
this could change the way cancer is treated
-
5:24
study shows that there is slower cancer drug approval in europe
-
42:31
overview of the european medicines agency (ema), part 1 of 3
-
30:55
drug discovery and development explained!
-
6:42
what is the the european medicines agency?
-
2:01
clinical trials in the eu - sk version
-
1:03
the medicines adaptive pathways to patients (mapps) and its importance in oncology
-
1:24
ema from lab to patient - (multi-language)
-
1:58
what ema does for public and animal health
-
30:24
s1 overview of ema-approved anti-cancer products
-
42:24
the new cancer drugs - helpful or harmful? | dw documentary
-
1:31
the importance of the european medicines agency in car-t development
-
1:41:06
strenghtening the lung cancer patient voice in health policy and regulatory decision
-
12:27
european medicines agency overview | marketing authorisation procedures in europe - ma in eu
-
4:26
fabrizia bignami (eurordis), speaks about 10 years of orphan drug regulation in europe.